These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 25841749)

  • 1. Reregulation of the Swedish pharmacy sector-A qualitative content analysis of the political rationale.
    Wisell K; Winblad U; Sporrong SK
    Health Policy; 2015 May; 119(5):648-53. PubMed ID: 25841749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stakeholders' expectations and perceived effects of the pharmacy ownership liberalization reform in Sweden: a qualitative interview study.
    Wisell K; Winblad U; Sporrong SK
    BMC Health Serv Res; 2016 Aug; 16(1):379. PubMed ID: 27519573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diversity as salvation? - A comparison of the diversity rationale in the Swedish pharmacy ownership liberalization reform and the primary care choice reform.
    Wisell K; Winblad U; Kälvemark Sporrong S
    Health Policy; 2019 May; 123(5):457-461. PubMed ID: 30890380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China.
    Fang Y; Wagner AK; Yang S; Jiang M; Zhang F; Ross-Degnan D
    Lancet Glob Health; 2013 Oct; 1(4):e227-37. PubMed ID: 25104348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does deregulation in community pharmacy impact accessibility of medicines, quality of pharmacy services and costs? Evidence from nine European countries.
    Vogler S; Habimana K; Arts D
    Health Policy; 2014 Sep; 117(3):311-27. PubMed ID: 24962537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Raison D'être for the Community Pharmacy and the Community Pharmacist in Sweden: A Qualitative Interview Study.
    Wisell K; Sporrong SK
    Pharmacy (Basel); 2015 Dec; 4(1):. PubMed ID: 28970376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purchase habits, use of paracetamol, and information sources on a reregulated Swedish pharmacy market: A population-based study.
    Hedenrud T; Håkonsen H
    Health Policy; 2017 Jan; 121(1):35-41. PubMed ID: 27890394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consumer preferences for over-the-counter drug retailers in the reregulated Swedish pharmacy market.
    Håkonsen H; Sundell KA; Martinsson J; Hedenrud T
    Health Policy; 2016 Mar; 120(3):327-33. PubMed ID: 26861972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-examining 'professionalism' in pharmacy: a South African perspective.
    Williams KF
    Soc Sci Med; 2007 Mar; 64(6):1285-96. PubMed ID: 17161511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Entry of new pharmacies in the deregulated Norwegian pharmaceuticals market--consequences for costs and availability.
    Rudholm N
    Health Policy; 2008 Aug; 87(2):258-63. PubMed ID: 18164509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of information systems at pharmacies - a case study from the re-regulated pharmacy market in Sweden.
    Hammar T; Ohlson M; Hanson E; Petersson G
    Res Social Adm Pharm; 2015; 11(2):e85-99. PubMed ID: 25205612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms behind privatization: a case study of private growth in Swedish elderly care.
    Stolt R; Winblad U
    Soc Sci Med; 2009 Mar; 68(5):903-11. PubMed ID: 19136187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lessons from Korea's pharmaceutical policy reform: the separation of medical institutions and pharmacies for outpatient care.
    Kim HJ; Chung W; Lee SG
    Health Policy; 2004 Jun; 68(3):267-75. PubMed ID: 15113638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [From community pharmacies to big pharmacy chains: private provision of medicines, health system, and financialization of the Brazilian retail pharmacy market].
    Mattos LV; Silva RMD; Silva FDRPD; Luiza VL
    Cad Saude Publica; 2022; 38Suppl 2(Suppl 2):e00085420. PubMed ID: 36043623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceutical care in community pharmacies: practice and research in Sweden.
    Westerlund LT; Björk HT
    Ann Pharmacother; 2006 Jun; 40(6):1162-9. PubMed ID: 16735653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case for government ownership of primary care services in New Zealand: weighing the arguments.
    Crampton P; Starfield B
    Int J Health Serv; 2004; 34(4):709-27. PubMed ID: 15560431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug experts of the future, today?--depiction of the pharmacist profession in Swedish professional and lay print media.
    Carlsson JR; Renberg T; Sporrong SK
    Res Social Adm Pharm; 2012; 8(2):133-44. PubMed ID: 21511542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationales and arguments behind the adoption of self-selection of nonprescription medicines in Denmark.
    Jacobsen SN; Møller-Jensen SE; Sporrong SK
    J Pharm Policy Pract; 2020; 13():29. PubMed ID: 32670593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Explaining Large-Scale Policy Change in the Turkish Health Care System: Ideas, Institutions, and Political Actors.
    Agartan TI
    J Health Polit Policy Law; 2015 Oct; 40(5):971-99. PubMed ID: 26195607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical care in community pharmacies: practice and research in Estonia.
    Volmer D; Vendla K; Vetka A; Bell JS; Hamilton D
    Ann Pharmacother; 2008 Jul; 42(7):1104-11. PubMed ID: 18577761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.